The Inside Knowledge: Get the Facts About Gynecologic Cancer campaign raises awareness of the five main types of gynecologic cancer: cervical, ovarian, uterine, vaginal, and vulvar. It encourages women to pay attention to their bodies and know what is normal for them so they can recognize the warning signs of gynecologic cancers and seek medical care. This report provides an overview of the development of this national campaign.
Get full access to this article
View all access options for this article.
References
1.
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2007. Incidence and mortality web-based report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2010.
2.
Cancer survivors—United States 2007. MMWR, 2011; 60:269–272.
3.
OzolsR, BundyB, GreerBet al.Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol, 2003; 21:3194–3200.
4.
FordD, EastonD, StrattonMet al.Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 1998; 62:676–689.
5.
DomchekS, FriebelT, SingerCet al.Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, 2010; 304:967–975.
6.
LuK, DinhM, KohlmannWet al.Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol, 2005; 105:569–574.
7.
ParkinD, BrayF. The burden of HPV-related cancers. Vaccine, 2006; 24,Suppl 3:S11–S25.
8.
CooperC, PolonecL, GelbC. Women's knowledge and awareness of gynecologic cancer: A multisite qualitative study in the United States. J Womens Health, 2011; 20:517–524.
9.
BlakeD, WeberB, FletcherK. Adolescent and young adult women's misunderstanding of the term Pap smear. Arch Pediatr Adolesc Med, 2004; 158:966–970.
10.
BreitkopfC, PearsonH, BreitkopfD. Poor knowledge regarding the Pap test among low-income women undergoing routine screening. Perspect Sex Reprod Health, 2005; 37:78–84.
11.
HeadS, CrosbyR, MooreG. Pap smear knowledge among young women following the introduction of the HPV vaccine. J Pediatr Adolesc Gynecol, 2009; 22:251–256.
12.
MassadLS, MeyerP, HobbsJ. Knowledge of cervical cancer screening among women attending urban colposcopy clinics. Cancer Detect Prev, 1997; 21:103–109.
13.
HawkinsN, CooperC, SaraiyaM, GelbC, PolonecL. Why the Pap test? Awareness and use of the Pap test among women in the United States. J Womens Health, 2011; 20:511–515.
14.
StewartRA, ThistlethwaiteJ, EvansR. Pelvic examination of asymptomatic women—Attitudes and clinical practice. Aust Fam Physician, 2008; 37:493–496.
15.
WesthoffC, JonesH, GuiahiM. Do new guidelines and technology make the routine pelvic examination obsolete?J Womens Health, 2011; 20:5–10.
16.
TriversK, RodriguezJ, HawkinsN, CooperC, PolonecL, GelbC. Care-seeking for symptoms associated with gynecologic cancers. Prev Chronic Dis, 2011in press.
17.
DalyMB, OzolsRF. Symptoms of ovarian cancer—where to set the bar?JAMA, 2004; 291:2755–2756.
GoffBA, MandelLS, MelanconCH, MuntzHG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA, 2004; 291:2705–2712.
20.
GoffBA, MandelLS, DrescherCWet al.Development of an ovarian cancer symptom index: Possibilities for earlier detection. Cancer, 2007; 109:221–227.
21.
SmithLH, MorrisCR, YasmeenS, Parikh-PatelA, CressRD, RomanoPS. Ovarian cancer: Can we make the clinical diagnosis earlier?Cancer, 2005; 104:1398–1407.
22.
RyersonAB, EhemanC, BurtonJet al.Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstet Gynecol, 2007; 109:1053–1061.
23.
BanduraA. Social foundations of thought and action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall, 1986.
24.
StewartSL, RimSH, GelbCA. Physician knowledge and awareness of CA-125 as a screen for ovarian cancer in the asymptomatic, average-risk population. Health Educ Behav, 2011[Epub ahead of print]
25.
EarleCC, SchragD, NevilleBAet al.Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst, 2006; 98:172–180.
